Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B

Journal of Medical Virology

Volumn 85, Issue 6, 2013, Pages 979-986

  Huang, Xiangyan ^a   Qin, Yanghua ^b   Li, Wei ^a   Shi, Qingfen ^c   Xue, Yan ^a   Li, Jie ^a   Liu, Chao ^a   Hollinger, F Blaine ^d   Shen, Qian ^b  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c JINAN INFECTIOUS DISEASE HOSPITAL   (China)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Mutations; Occult hepatitis B; Pre S S gene; Serological tests

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CHINA; CODON; CONTROLLED STUDY; GENE DELETION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROLOGY; VIRUS GENE; VIRUS LOAD; VIRUS MUTATION;

ADULT; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CHINA; DNA, VIRAL; FEMALE; GENES, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX; VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 84876370404     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23556     Document Type: Article

References (43)

1. Allain JP. 2004. Occult hepatitis B virus infection. Transfus Clin Biol 11: 18-25.
2. Allain JP, Candotti D. 2009. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 7: 174-182.
3. Bes M, Vargas V, Piron M, Casamitjana N, Esteban JI, Vilanova N, Pinacho A, Quer J, Puig L, Guardia J, Sauleda S. 2012. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. J Hepatol 56: 765-774.
4. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. 2001. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"? Hepatology 34: 194-203.
5. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325-329.
6. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. 2006. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
7. Chen SJ, Zhao YX, Fang Y, Xu WZ, Ma YX, Song ZW, Teng X, Gu HX. 2012. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res 163: 197-201.
8. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC. 2007. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14: 161-168.
9. Datta S, Banerjee A, Chandra PK, Chowdhury A, Chakravarty R. 2006. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol 78: 53-59.
10. El Chaar M, Candotti D, Crowther RA, Allain JP. 2010. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 52: 1600-1610.
11. Fang Y, Teng X, Xu WZ, Li D, Zhao HW, Fu LJ, Zhang FM, Gu HX. 2009. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J Med Virol 81: 826-835.
12. Gerlich WH. 2004. Diagnostic problems caused by HBsAg mutants-A consensus report of an expert meeting. Intervirology 47: 310-313.
13. Hollinger FB. 2008. Hepatitis B virus infection and transfusion medicine: Science and the occult. Transfusion 48: 1001-1026.
14. Hollinger FB, Sood G. 2010. Occult hepatitis B virus infection: A covert operation. J Viral Hepat 17: 1-15.
15. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34: 1027-1034.
16. Hu KQ. 2002. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 9: 243-257.
17. Huang CH, Yuan Q, Chen PJ, Zhang YL, Chen CR, Zheng QB, Yeh SH, Yu H, Xue Y, Chen YX, Liu PG, Ge SX, Zhang J, Xia NS. 2012. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. J Hepatol 57: 720-729.
18. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. 2004. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73: 508-515.
19. Kalinina T, Iwanski A, Will H, Sterneck M. 2003. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38: 1274-1281.
20. Khan N, Guarnieri M, Ahn SH, Li J, Zhou Y, Bang G, Kim KH, Wands JR, Tong S. 2004. Modulation of hepatitisB virus secretion by naturally occurring mutations in the S gene. J Virol 78: 3262-3270.
21. Kramvis A, Kew M, François G. 2005. Hepatitis B virus genotypes. Vaccine 23: 2409-2423.
22. Lada O, Benhamou Y, Poynard T, Thibault V. 2006. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: Influence of "a" determinant variants. J Virol 80: 2968-2975.
23. Levicnik-Stezinar S. 2004. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab 50: 49-51.
24. Louisirirotchanakul S, Kanoksinsombat C, Theamboonlert A, Puthavatana P, Wasi C, Poovorawan Y. 2004. Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits. Viral Immunol 17: 440-444.
25. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47: 289-309.
26. Ogata N, Cote PJ, Zanetti AR, Miller RH, Shapiro M, Gerin J, Purcell RH. 1999. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 30: 779-786.
27. Osiowy C. 2002. Sensitive detection of HBsAg mutants by a gap-ligase chain reaction assay. J Clin Micro 40: 2566-2571.
28. Osiowy C. 2006. Detection of HBsAg mutants. J Med Virol 78: S48-S51.
29. Paparella C, De Rosa F, Longo R, Cappiello G, Ursitti A, Rosa M, Morosetti M, Spanò A. 2010. Appearance of HbeAg in an occult persistent hepatitis B virus infection. Intervirology 53: 173-175.
30. Schochetman G, Kuhns MC. 2006. HIV variants and hepatitis B surface antigen mutants: Diagnostic challenges for immunoassays. J Med Virol 78: S3-S6.
31. Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. 2012. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol 57: 515-521.
32. Sheldon J, Soriano V. 2008. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother 61: 766-768.
33. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. 2011. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 364: 236-247.
34. Svicher V, Cento V, Bernassola M, Neumann-Fraune M, Van Hemert F, Chen M, Salpini R, Liu C, Longo R, Visca M, Romano S, Micheli V, Bertoli A, Gori C, Ceccherini-Silberstein F, Sarrecchia C, Andreoni M, Angelico M, Ursitti A, Spanò A, Zhang JM, Verheyen J, Cappiello G, Perno CF. 2012. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res 93: 86-93.
35. Tabor E. 2006. Infections by hepatitis B surface antigen gene mutants in Europe and North America. J Med Virol 78: S43-S47.
36. Veropalumbo E, Marrone A, Vallefuoco L, Perruolo G, Orlando R, Scordino F, Tosone G, Zampino R, Trani B, Genovese A, Spadaro G, D'Orio C, Portella G. 2010. Immunocompromised patients with HBsAg a determinant mutants: Comparison of HBsAg diagnostic assays. Intervirology 53: 183-187.
37. Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzucco W, Virdone R, Palazzo U, Villafrate MR, Tagger A, Romano N. 2008. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of OBI? J Med Virol 80: 577-582.
38. Wagner AA, Denis F, Weinbreck P, Loustaud V, Autofage F, Rogez S, Alain S. 2004. Serological pattern "anti-hepatitis B core alone" in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 18: 569-571.
39. Weber B. 2005. Genetic variability of the S gene of hepatitis B virus: Clinical and diagnostic impact. J Clin Virol 32: 102-112.
40. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78: S59-S65.
41. Werr M, Prange R. 1998. Role for calnexin and N-Linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J Virol 72: 778-782.
42. Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH, Yeo AE, Shih JW, Zhang J, Xia NS. 2010. Molecular characteristics of occult hepatitis B virus from blood donors in Southeast China. J Clin Microbiol 48: 357-362.
43. Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M. 2004. Mutant hepatitisB virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329: 454-464.